PhenoPath Laboratories, PLLC is a physician-owned specialty pathology practice and reference laboratory providing diagnostic and contract research services to pathology and oncology practices, hospitals, biopharmaceutical companies and research institutions in the U.S., Canada and around the world.
PhenoPath Laboratories’ test menu includes a broad array of state-of-the-art immunohistochemistry, flow cytometry, fluorescence in situ hybridization and molecular assays as well as chromosome analysis.
Hereditary non-polyposis colorectal carcinoma (HNPCC), also known as Lynch Syndrome, is an autosomal dominant hereditary cancer...Read More »
Regan Fulton, MD, PhD, Joins PhenoPath / ROS1 FISH / GATA-3: a novel marker of breast and urothelial carcinomas / PhenoCases
Read More »
Regan Fulton, MD, PhD Joins PhenoPathRead More »